Literature DB >> 7700069

Insulin and the renin-angiotensin-aldosterone system: influence of ACE inhibition.

E Ferrannini1, G Seghieri, E Muscelli.   

Abstract

This article focuses on the links between insulin and blood pressure at the level of the renin-angiotensin-aldosterone system (RAAS). The effects of insulin on plasma potassium levels and whole-body potassium content and the effect of potassium on glucose-induced insulin release identify a physiological glucose-potassium cycle. The normal interactions of insulin and hyperglycemia with the hormones of the RAAS are reviewed, and their changes in patients with diabetes mellitus are discussed. Some key findings on the interrelationships of insulin and the RAAS with regard to sodium metabolism are also brought into focus. A role for changes in the RAAS secondary to insulin resistance, hyperinsulinemia, and hyperglycemia is delineated in relation to the excess hypertension of diabetes. The effects of angiotensin-converting enzyme inhibition on insulin sensitivity and glucose tolerance are reviewed in the context of the glucose-potassium cycle.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7700069

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  8 in total

Review 1.  Optimal dosage of ACE inhibitors in older patients.

Authors:  B Tomlinson
Journal:  Drugs Aging       Date:  1996-10       Impact factor: 3.923

2.  Hyperinsulinemic Normoglycemia during Cardiac Surgery Reduces a Composite of 30-day Mortality and Serious In-hospital Complications: A Randomized Clinical Trial.

Authors:  Andra E Duncan; Daniel I Sessler; Hiroaki Sato; Tamaki Sato; Keisuke Nakazawa; George Carvalho; Roupen Hatzakorzian; Takumi Codere-Maruyama; Alaa Abd-Elsayed; Somnath Bose; Tamer Said; Maria Mendoza-Cuartas; Hyndhavi Chowdary; Edward J Mascha; Dongsheng Yang; A Marc Gillinov; Thomas Schricker
Journal:  Anesthesiology       Date:  2018-06       Impact factor: 7.892

Review 3.  Mineralocorticoid receptor antagonists and the metabolic syndrome.

Authors:  Amir Tirosh; Rajesh Garg; Gail K Adler
Journal:  Curr Hypertens Rep       Date:  2010-08       Impact factor: 5.369

Review 4.  Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.

Authors:  André J Scheen
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 5.  Angiotensin and insulin resistance: conspiracy theory.

Authors:  Raymond R Townsend
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

Review 6.  Antihypertensive treatment and new-onset diabetes mellitus.

Authors:  Tonje Amb Aksnes; Henrik M Reims; Sverre E Kjeldsen; Giuseppe Mancia
Journal:  Curr Hypertens Rep       Date:  2005-08       Impact factor: 5.369

7.  Association of Angiotensin Converting Enzyme Insertion-Deletion Polymorphism with Hypertension in Emiratis with Type 2 Diabetes Mellitus and Its Interaction with Obesity Status.

Authors:  Habiba Alsafar; Ahmed Hassoun; Shaikha Almazrouei; Wala Kamal; Mustafa Almaini; Unini Odama; Naushad Rais
Journal:  Dis Markers       Date:  2015-09-29       Impact factor: 3.434

8.  Eplerenone Implantation Improved Adipose Dysfunction Averting RAAS Activation and Cell Division.

Authors:  Andrea Vecchiola; Cristóbal A Fuentes; Isidora Solar; Carlos F Lagos; Maria Cecilia Opazo; Natalia Muñoz-Durango; Claudia A Riedel; Gareth I Owen; Alexis M Kalergis; Carlos E Fardella
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-21       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.